LIF Antikörper
Kurzübersicht für LIF Antikörper (ABIN327898)
Target
Alle LIF Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Spezifität
- Recognizes recombinant human Leukemia Inhibitory Factor (LIF) and to endogenous protein. Cross reactivity was observed against recombinant murine LIF. No reactivity was observed with recombinant rat LIF.
-
Aufreinigung
- Protein G purified
-
Immunogen
-
Monoclonal recombinant human Leukemia Inhibitory Factor (LIF).
Type of Immunogen: Recombinant protein -
Isotyp
- IgG1
-
-
-
-
Applikationshinweise
-
Approved: WB (1 μg/mL)
Usage: Suitable for use in Western Blot. Western Blot: 1 μg/mL.
Not recommended for: IHC-P -
Kommentare
-
Target Species of Antibody: Human
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- Lot specific
-
Buffer
- PBS, pH 7.6, 0.09 % sodium azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- avoid freeze thaw cycles.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- Short term 4°C, long term aliquot and store at -20°C, avoid freeze-thaw cycles.
-
-
- LIF (Leukemia Inhibitory Factor (LIF))
-
Andere Bezeichnung
- LIF
-
Hintergrund
-
Name/Gene ID: LIF
Synonyms: LIF, DIA, Emfilermin, HILDA, Melanoma-derived LPL inhibitor, MLPLI, Leukemia inhibitory factor, CDF, D factor, Human interleukin in DA cells -
Gen-ID
- 3976
-
UniProt
- P15018
-
Pathways
- JAK-STAT Signalweg, Positive Regulation of Peptide Hormone Secretion, Negative Regulation of Hormone Secretion, Stem Cell Maintenance, Growth Factor Binding
Target
-